Issued Patents All Time
Showing 26–50 of 368 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11667611 | Compositions and methods for inhibition of the JAK pathway | Ankush Argade, Arvinder Sran, David Carroll, Jeffrey Clough, Kin Tso +5 more | 2023-06-06 |
| 11608336 | Prodrugs of fused-bicyclic C5aR antagonists | Pingchen Fan, Rebecca M. Lui, Venkat Reddy Mali, Yibin Zeng, Penglie Zhang | 2023-03-21 |
| 11603356 | Amorphous form of a complement component C5a receptor | Kwok YAU, Kenken Luong, Yibin Zeng, Penglie Zhang, Manmohan Reddy Leleti +1 more | 2023-03-14 |
| 11530194 | Amide compounds and method for making and using | Kin Tso, Hui Li, Yan Chen, Rose Yen, Vanessa Taylor +2 more | 2022-12-20 |
| 11524955 | 2,4-diamino-pyrimidine compounds and method for making and using the compounds | Yan Chen, Rose Yen, Jiaxin Yu, Vanessa Taylor | 2022-12-13 |
| 11492349 | IRAK inhibitors and method for making and using | Hui Li, Thilo J. Heckrodt, Yan Chen, Ryan Kelley, Darren McMurtrie +4 more | 2022-11-08 |
| 11485737 | Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors | Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Viengkham Malathong, Venkat Reddy Mali +3 more | 2022-11-01 |
| 11485708 | Compounds for treatment of PD-L1 diseases | Viengkham Malathong, Pingchen Fan, Christopher W. Lange, Venkat Reddy Mali, Darren McMurtrie +4 more | 2022-11-01 |
| 11466018 | TGF-β inhibitors | Marina Gelman, Todd Kinsella, Somasekhar Bhamidipati, Ihab Darwish, Jiaxin Yu | 2022-10-11 |
| 11446289 | Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors | Shijie LI, Venkat Reddy Mali, Ju Yang, Penglie Zhang | 2022-09-20 |
| 11434230 | 2-oxindole compounds | Xi Chen, Dean R. Dragoli, Pingchen Fan, Manmohan Reddy Leleti, Rebecca M. Lui +6 more | 2022-09-06 |
| 11427541 | Salt forms of a complement component C5A receptor | Kwok YAU, Yibin Zeng, Penglie Zhang, Rebecca M. Lui, Ju Yang +1 more | 2022-08-30 |
| 11426364 | Immunomodulator compounds | Christopher W. Lange, Viengkham Malathong, Darren McMurtrie, Sreenivas Punna, Ju Yang +1 more | 2022-08-30 |
| 11384085 | Modulators of ion channel receptors and uses thereof | Belinda Huff, Courtney HOLLIS, Hamish Toop, Nathan Kuchel, Lorna Helen Mitchell | 2022-07-12 |
| 11384079 | 6-5 fused rings as C5a inhibitors | Pingchen Fan, Christopher W. Lange, Rebecca M. Lui, Viengkham Malathong, Venkat Reddy Mali +4 more | 2022-07-12 |
| 11382915 | Treatment of focal segmental glomerulosclerosis with CCR2 antagonists | Zhenhua Miao, Thomas Schall | 2022-07-12 |
| 11370808 | Pyrazole compounds and methods for making and using the compounds | Ryan Kelley, Hui Li, Thilo J. Heckrodt, Yan Chen, Darren McMurtrie +4 more | 2022-06-28 |
| 11352360 | TGF-beta inhibitors | Todd Kinsella, Marina Gelman, Hui Hong, Ihab Darwish, Jiaxin Yu +6 more | 2022-06-07 |
| 11324736 | Method of Treating Focal Segmental Glomerulosclerosis | Zhenhua Miao, Thomas Schall | 2022-05-10 |
| 11304952 | Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor | James J. CAMPBELL, Zhenhua Miao, Thomas Schall, Israel Charo, Shijie LI +2 more | 2022-04-19 |
| 11299486 | Benzazole compounds and methods for making and using the compounds | Rose Yen, Yan Chen, Vanessa Taylor | 2022-04-12 |
| 11279686 | Nrf2 activating compounds and uses thereof | Matthew Duncton | 2022-03-22 |
| 11266643 | Triaryl compounds for treatment of PD-L1 diseases | Pingchen Fan, Christopher W. Lange, Venkat Reddy Mali, Darren McMurtrie, Viengkham Malathong +4 more | 2022-03-08 |
| RE48898 | Prodrugs of 2,4-pyrimidinediamine compounds and their uses | Somasekhar Bhamidipati, Thomas Sun, Esteban Masuda | 2022-01-25 |
| 11230554 | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds | Ankush Argade, Hui Li, Somasekhar Bhamidipati, David Carroll, Catherine Sylvain +2 more | 2022-01-25 |